Skip to main content
UTI logo

UTI · Universal Technical Institute Inc

Track UTI — free
$22.09 +0.10 (+0.45%)
Market Cap
$1.21B
Shares
55.10M
Volume · Nov 16 180.6K Avg daily vol (3M) 1.62M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$21.99 Open$22.05 Day$21.42–22.90 52W close$18.47–51.20 Avg vol 30d1.4M Short int7.7M · 14.0% of shares · 5.5d Short vol62% Last earningsAug 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Aug 6

Up next

Nov 18, 2026 Scheduled · this week

Latest documents

2026
Aug 6
Quarterly report 10-Q FY2026 Q3, ended Jun 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $218.91M ▲ 7.2% Net income $2.28M ▼ 78.6% Diluted EPS $0.04 ▼ 78.9%
May 7
Quarterly report 10-Q FY2026 Q2, ended Mar 31
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $221.4M ▲ 6.7% Net income $433K ▼ 96.2% Diluted EPS $0.01 ▼ 95.2%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$883.60M
Trailing 12 months
Net income (TTM)
$34.30M
Trailing 12 months
Revenue growth YoY
+7.2%
Year over year
Operating margin
5.0%
Trailing 12 months
P / E (TTM)
36.0
Trailing earnings · reciprocal yield 2.8%
FCF yield
-1.9%
TTM · current market cap
Return on invested capital
10.0%
Trailing 12 months
Net cash
$10.09M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.5%
Year over year · more shares
Price change (1Y)
-25.2%
Trailing year
Short interest
14.0%
Latest settlement · 5.5 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −31%
below
Price vs 50-day avg +5%
above
RSI (14) 52
neutral
MACD trend Positive
52-week position 11%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +7%
trailing
6-month return −45%
trailing
YTD return −16%
this year
Relative strength −45%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $21 › 200d $32 — 200d above 50d
Institutional flow Distributing
237 of 270 funds reported for Sep 30 · net -3.1M sh shares · +26 new
Insider flow Accumulating
Net +$83.1K over 90 days · 0% sells
Short interest Rising
13.96% of shares out · ▲ +12.7% MoM · 5.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
270 holders — near 3-yr high, broad support
Squeeze score 92
high risk · 0–100
Fundamentals
Excellent
Revenue growth +14%
Y/Y
EPS growth +51%
Y/Y
Free cash flow $55.4M
Valuation P/E 36.1
rich
Buyback $35.0M
authorized
Balance sheet $40.3M
net cash
Quant / Vol
risk profile
Very High
Volatility 69%
annualized · 1-yr
Max drawdown −64%
past year
ATR 6.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 6 of last 7
Latest guidance · from the Earnings Call filed Aug 5, 2026
Adjusted EBITDA · fiscal 2029 Non-GAAP Maintained $220M
May 6, 2026 $220M changed to Aug 5, 2026 $220M
Previous outlook earlier release · from the Earnings Call filed Feb 4, 2026

Still-open targets the latest release did not restate under the same label.

Revenue · Fiscal 2029 at least $1.2B
Prior guidance period ended · from the Earnings Call filed Aug 5, 2026
Net income · fiscal 2026 $32M – $36M
Diluted earnings per share · fiscal 2026 $0.57 – $0.64
Baseline adjusted EBITDA · fiscal 2026 at least $135M
Reported adjusted EBITDA · fiscal 2026 $100M – $103M
Capital expenditures · fiscal 2026 $110M
Consolidated revenue · fiscal 2026 $893M – $900M
Guided vs delivered · last 7 settled
Diluted EPS FY 2025
guided $1.00 – $1.08
$1.13 Beat +8.7%
Diluted EPS FY 2024
guided $0.68 – $0.73
$0.75 Beat +6.4%
Revenue fiscal 2024
guided $720M – $730M
$732.69M Beat +1.1%
Revenue FY 2023
guided $595M – $610M
$607.41M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−31% Bearish
Price vs 50-day avg
+5% Bullish
RSI (14)
52 Neutral
MACD trend
Positive Bullish
52-week position
11% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $21 › 200d $32 — 200d above 50d
Institutional flow Distributing
237 of 270 funds reported for Sep 30 · net -3.1M sh shares · +26 new
Insider flow Accumulating
Net +$83.1K over 90 days · 0% sells
Short interest Rising
13.96% of shares out · ▲ +12.7% MoM · 5.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
270 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $18 Now $22 · 11% Range high $51
vs 200-day avg -31% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Concorde End of period full-time active students 9,806 Three Months Ended June 30, 2026 filing —
Concorde Total new student starts 2,851 Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income 2.28M
-764K Interest income
+1.01M Interest expense
+820K Income tax (benefit) expense
+10.41M Depreciation and amortization
= EBITDA 13.76M
UTI End of period full-time active students 14,602 Three Months Ended June 30, 2026 filing —
UTI Total new student starts 3,491 Three Months Ended June 30, 2026 filing —
Adjusted free cash flow non-GAAP -$21.4M Q3 FY2026 —
Adjusted Free Cash Flow, non-GAAP non-GAAP $55.98M Fiscal 2025 —
Baseline adjusted EBITDA non-GAAP $27.2M Q3 FY2026 —
Concorde Average full-time active students 10,364 Q3 FY2026 —
Concorde New student starts 2,851 Q3 FY2026 —
Concorde Revenue per student $7,800 Q3 FY2026 —
End of period full-time active students 24,408 Nine Months Ended June 30, 2026 —
Free cash flow, non-GAAP non-GAAP $55.35M Fiscal 2025 —
LTM EBITDA non-GAAP $96.2M As of 6/30/2026 —
Total available liquidity $180.5M Q3 FY2026 —
Total Full-Time Active Students 25,131 Q3 FY2026 —
UTI Adjusted EBITDA non-GAAP $14.3M Q3 FY2026 —
UTI Average full-time active students 14,767 Q3 FY2026 —
UTI New student starts 3,491 Q3 FY2026 —
UTI Revenue per student $9,300 Q3 FY2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Education & Training Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
UTI
Universal Technical Institute Inc
this stock
$1.21B -15.8% +14.0% 36.1 14.0%
EDU
New Oriental Education & Technology Group Inc.
$8.26B -3.2% +15.5% — 1.6%
TAL
TAL Education Group
$5.70B -5.8% +33.7% — 3.7%
LAUR
Laureate Education, Inc.
$4.68B +4.0% +19.5% 12.8 2.4%
CVSA
Covista Inc.
$3.93B +14.2% +9.3% 16.1 8.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
233
% held
106.5%
Reported
237 of 270
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
291
View
Short & Settlement
Short Interest Rising
Shares short
7.7M
Days to cover
5.5d
Change
+869.8K sh
View
Short Volume
Short vol %
62%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
57
Value
$1.3K
As of
Oct 28, 2026
View
Off-Exchange
Off-exchange %
45.5%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$83.1K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$835.6M
Net income (FY)
$63.0M
EPS diluted
$1.13
View
Buybacks
Authorized
$35.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 18, 2026
This year
12
View
Proposed Sales
Value
$3.9M
Shares
94.5K
Filed
Jun 29, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 18, 2026
Last webcast
Sep 22, 2026
View
Investor Relations
Latest news
Universal Technical Institute, In…
Published
Oct 29, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
UTI +10.3% +6.9% -45.0% -2.9% -15.8%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +7.8% +8.0% -45.5% -2.7% -26.5%

Capital returns

Buyback program · as of Jun 30, 2025
Authorized
$35.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1261654 CUSIP 913915104 13F (30d) 181 filings 163 filers Visit website Investor relations